Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 08:34 am Sale |
2022-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Deep Track Capital, LP | 0 0.000% |
-2,686,655![]() (Position Closed) |
Filing History |
2022-10-14 4:03 pm Sale |
2022-10-14 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 0 0.000% |
-9,040,309![]() (Position Closed) |
Filing History |
2022-09-02 4:30 pm Purchase |
2022-08-31 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,040,309 18.880% |
11,125![]() (+0.12%) |
Filing History |
2022-06-03 4:12 pm Purchase |
2022-05-26 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Deep Track Capital, LP | 2,686,655 5.620% |
2,686,655![]() (New Position) |
Filing History |
2022-05-10 10:13 am Sale |
2022-05-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 222,990 0.492% |
-3,654,062![]() (-94.25%) |
Filing History |
2022-02-14 3:13 pm Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 4,639,998 9.790% |
179,998![]() (+4.04%) |
Filing History |
2022-02-11 4:31 pm Sale |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Novartis Bioventures Ltd | 1,757,057 3.710% |
-1,234,648![]() (-41.27%) |
Filing History |
2022-02-10 4:29 pm Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
LILLY ELI & CO LLY |
339,191 0.700% |
339,191![]() (New Position) |
Filing History |
2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
The Vanguard Group | 2,860,653 6.030% |
2,860,653![]() (New Position) |
Filing History |
2022-02-09 09:19 am Sale |
2022-02-08 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 3,877,052 8.178% |
-873,437![]() (-18.39%) |
Filing History |
2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
BLACKROCK INC BLK |
3,026,666 6.400% |
391,916![]() (+14.87%) |
Filing History |
2021-10-28 4:32 pm Purchase |
2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,029,184 19.050% |
17,533![]() (+0.19%) |
Filing History |
2021-03-10 09:46 am Purchase |
2021-03-09 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 4,750,489 10.615% |
634,841![]() (+15.43%) |
Filing History |
2021-02-16 3:06 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 4,460,000 9.970% |
1,080,630![]() (+31.98%) |
Filing History |
2021-02-12 5:16 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Lilly Ventures Fund I LLC | 2,404,069 5.200% |
2,404,069![]() (New Position) |
Filing History |
2021-02-08 10:21 am Purchase |
2021-02-05 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
FMR CORP | 4,115,648 9.196% |
4,115,648![]() (New Position) |
Filing History |
2021-02-02 3:16 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
BLACKROCK INC BLK |
2,634,750 5.700% |
2,634,750![]() (New Position) |
Filing History |
2021-02-01 4:09 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Novartis Bioventures Ltd | 2,991,705 6.690% |
2,991,705![]() (New Position) |
Filing History |
2020-07-06 4:01 pm Purchase |
2020-06-23 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Cormorant Asset Management LP | 3,379,370 8.760% |
3,379,370![]() (New Position) |
Filing History |
2020-06-25 5:02 pm Purchase |
2009-02-28 | 13D | Forma Therapeutics Holdings, Inc. FMTX |
RA Capital Management, L.P. | 9,011,651 23.400% |
9,011,651![]() (New Position) |
Filing History |